PENTAIR ($PNR) is expected to release its quarterly earnings data on Tuesday, October 21st before market open, per Finnhub. Analysts are expecting revenue of $1,015,111,852 and earnings of $1.19 per share.
You can see Quiver Quantitative's $PNR stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
PENTAIR Insider Trading Activity
PENTAIR insiders have traded $PNR stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $PNR stock by insiders over the last 6 months:
- DAVID A /WI JONES sold 6,558 shares for an estimated $589,827
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PENTAIR Hedge Fund Activity
We have seen 340 institutional investors add shares of PENTAIR stock to their portfolio, and 322 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,871,034 shares (+807.9%) to their portfolio in Q2 2025, for an estimated $192,080,350
- VALEO FINANCIAL ADVISORS, LLC added 1,002,776 shares (+inf%) to their portfolio in Q2 2025, for an estimated $102,944,984
- AMUNDI removed 824,423 shares (-16.6%) from their portfolio in Q2 2025, for an estimated $84,635,265
- ALYESKA INVESTMENT GROUP, L.P. added 715,575 shares (+3140.8%) to their portfolio in Q2 2025, for an estimated $73,460,929
- UBS GROUP AG removed 645,783 shares (-47.6%) from their portfolio in Q2 2025, for an estimated $66,296,082
- IMPAX ASSET MANAGEMENT GROUP PLC removed 559,474 shares (-11.3%) from their portfolio in Q2 2025, for an estimated $57,435,600
- PANAGORA ASSET MANAGEMENT INC added 514,571 shares (+77.4%) to their portfolio in Q2 2025, for an estimated $52,825,858
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PENTAIR Congressional Stock Trading
Members of Congress have traded $PNR stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $PNR stock by members of Congress over the last 6 months:
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
PENTAIR Analyst Ratings
Wall Street analysts have issued reports on $PNR in the last several months. We have seen 9 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 10/15/2025
- Barclays issued a "Overweight" rating on 10/01/2025
- B of A Securities issued a "Underperform" rating on 07/29/2025
- Baird issued a "Outperform" rating on 07/23/2025
- Oppenheimer issued a "Outperform" rating on 07/23/2025
- Mizuho issued a "Outperform" rating on 07/23/2025
- Stifel issued a "Buy" rating on 07/21/2025
To track analyst ratings and price targets for PENTAIR, check out Quiver Quantitative's $PNR forecast page.
PENTAIR Price Targets
Multiple analysts have issued price targets for $PNR recently. We have seen 12 analysts offer price targets for $PNR in the last 6 months, with a median target of $120.5.
Here are some recent targets:
- Stephen Tusa from JP Morgan set a target price of $126.0 on 10/15/2025
- Andrew Kaplowitz from Citigroup set a target price of $133.0 on 10/09/2025
- Julian Mitchell from Barclays set a target price of $125.0 on 10/01/2025
- Andrew Obin from B of A Securities set a target price of $100.0 on 07/29/2025
- Joseph Giordano from TD Cowen set a target price of $110.0 on 07/23/2025
- Bryan Blair from Oppenheimer set a target price of $120.0 on 07/23/2025
- Brett Linzey from Mizuho set a target price of $122.0 on 07/23/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
